Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00189774
Status:
COMPLETED
Last Update Posted:
2008-03-13
First Post:
2005-09-13
Brief Title:
Nateglinide a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic Patients
Sponsor:
Astellas Pharma Inc
Organization:
Astellas Pharma Inc
Organization Data
Organization:
Astellas Pharma Inc
Class:
INDUSTRY
Study ID:
026-CL-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Astellas Pharma Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Ajinomoto USA INC | INDUSTRY |